The effect of renal transplantation on hyperhomocysteinaemia in dialysis patients, and the estimation of renal homocysteine extraction in patients with normal renal function

Netherlands Journal of Medicine

Volumn 52, Issue 2, 1998, Pages 58-64

  Van Guldener, C ^a   Janssen, M J F M ^b   Stehouwer, C D A ^a   Jakobs, C ^b   Bronzwaer, J G F ^b   Surachno, J ^c   Donker, A J M ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Chronic renal failure; Homocysteine; Hyperhomocysteinemia; Kidney transplantation; Renal metabolism

Indexed keywords

HOMOCYSTEINE;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; DIALYSIS; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; KIDNEY FUNCTION; KIDNEY METABOLISM; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; PATHOPHYSIOLOGY; URINARY EXCRETION; VENOUS BLOOD;

ADULT; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0031966099     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(97)00069-7     Document Type: Article

References (30)

1. Excerpts from the USRDS 1996 annual data report. Am J Kidney Dis, 1996;28:S79-S102.
2. Wilcken D.E.L., Gupta V.J., Reddy S.G. Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis. Clin. Sci. 58:1980;427-430.
3. Smolin L.A., Laidlaw S.A., Kopple J.D. Altered plasma free and protein-bound sulfur amino acid levels in patients undergoing maintenance hemodialysis. Am. J. Clin. Nutr. 45:1987;737-743.
4. Hultberg B., Andersson A., Sterner G. Plasma homocysteine in renal failure. Clin. Nephrol. 40:1993;230-235.
5. Chauveau P., Chadefaux B., Coudé M.et al. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int. 43:1993;S72-S77.
6. Bostom A.G., Shemin D., Lapane K.L.et al. Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study. Atherosclerosis. 114:1995;93-103.
7. Bachmann J., Tepel M., Raidt H.et al. Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J. Am. Soc. Nephrol. 6:1995;121-125.
8. Janssen M.J.F.M., van Guldener C., de Jong G.M.T., van den Berg M., Stehouwer C.D.A., Donker A.J.M. Folic acid treatment of hyperhomocysteinemia in dialysis patients. Miner. Electrolyte Metab. 22:1996;110-114.
9. Robinson K., Gupta A., Dennis V.et al. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation. 94:1996;2743-2748.
10. Wilcken D.E.L., Gupta V.J., Betts A.K. Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism. Clin. Sci. 61:1981;743-749.
11. Janssen M.J.F.M., van den Berg M., Stehouwer C.D.A., Boers G.H.J. Hyperhomocysteinaemia: a role in the accelerated atherogenesis of chronic renal failure? Neth. J. Med. 46:1995;244-251.
12. Wilcken D.E.L., Gupta V.J. Sulfur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide. Eur. J. Clin. Invest. 9:1979;301-307.
13. Arnadottir M., Hultberg B., Nilsson-Ehle P., Thysell H. The effect of reduced glomerular filtration rate on plasma homocysteine concentration. Scand. J. Clin. Lab. Invest. 56:1996;41-46.
14. Refsum H., Helland S., Ueland P.M. Radioenzymic determination of homocysteine in plasma and urine. Clin. Chemistry. 31:1985;624-628.
15. Stabler S.P., Marcell P.D., Podell E.R., Allen R.H. Quantitation of total homocysteine total cysteine, and methionine in normal serum and urine using capillary gas chromatography-mass spectrometry. Anal. Biochem. 162:1987;185-196.
16. Massy Z.A., Chadefaux-Vekemans B., Chevalier A.et al. Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients. Nephrol. Dial. Transplant. 9:1994;1103-1108.
17. Bostom A.G., Brosnan J.T., Hall B., Nadeau M.R., Selhub J. Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis. 116:1995;59-62.
18. Ubbink J.B., Vermaak W.J.H., Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J. Chromatogr. 565:1991;441-446.
19. van den Berg M., Franken D.G., Boers G.H.J.et al. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J. Vasc. Surg. 20:1994;933-940.
20. Bland J.M., Altman D.G. Calculating correlation coefficients with repeated observations. Part 1 - correlation within subjects Br. Med. J. 310:1995;446.
21. Bocock M.A., Zlotkin S.H. Hepatic sulfur amino acid metabolism in rats with chronic renal failure. J. Nutr. 120:1990;691-699.
22. Pazmiño P.A., Rogoff F., Weinshilboum R.M. Inhibition of human erythrocyte phenol-O-methyltransferase in uremia. Clin. Pharmacol. Ther. 26:1979;464-472.
23. Pazmiño P.A., Weinshilboum R.M. Catechol-O-methyltransferase in uremia: elevated erythrocyte activity and plasma inhibitors. Kidney Int. 16:1979;954. Abstract.
24. Pazmiño P.A., Sladek S.L., Weinshilboum R.M. Thiol S-methylation in uremia: erythrocyte enzyme activities and plasma inhibitors. Clin. Pharmacol. Ther. 28:1980;356-367.
25. Livant E.J., Tamura T., Johnston K.E.et al. Plasma folate conjugase activities and folate concentrations in patients receiving hemodialysis. J. Nutr. Biochem. 5:1994;504-508.
26. Sturman J.A., Rassin D.K., Gaull G.E. Distribution of transsulphuration enzymes in various organs and species. Int. J. Biochem. 1:1970;251-253.
27. McKeever M.P., Weir D.G., Molloy A., Scott J.M. Betaine-homocysteine methyltransferase: organ distribution in man, pig, and rat and subcellular distribution in the rat. Clin. Sci. 81:1991;551-556.
28. Gaull G.E., von Berg W., Räihä N.C.R., Sturman J.A. Development of methyltransferase activities of human fetal tissues. Pediatr. Res. 7:1973;527-533.
29. Malinow M.R. Homocyst(e)ine and arterial occlusive diseases. J. Intern. Med. 236:1994;603-617.
30. ten Dam M.A.G.J., ten Kate R.W., Werter C.J.P.J., van Kamp G.J., Meuwissen S.G.M., Donker A.J.M. Measurement of the glomerular sieving coefficient of endogenous proteins in man. Contrib. Nephrol. 83:1990;47-52.